NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q3 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,254,000 | -29.5% | 329,920 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,778,000 | -60.1% | 329,920 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $4,457,000 | -31.7% | 329,920 | -9.2% | 0.00% | -40.0% |
| Q3 2021 | $6,522,000 | +6.9% | 363,166 | +2.1% | 0.01% | 0.0% |
| Q2 2021 | $6,101,000 | -23.3% | 355,535 | -10.6% | 0.01% | -16.7% |
| Q1 2021 | $7,956,000 | +3.9% | 397,797 | -11.7% | 0.01% | 0.0% |
| Q4 2020 | $7,659,000 | +27.2% | 450,529 | +24.1% | 0.01% | +20.0% |
| Q3 2020 | $6,021,000 | -26.3% | 362,900 | +2.9% | 0.01% | -37.5% |
| Q2 2020 | $8,169,000 | +33.0% | 352,700 | +2.5% | 0.01% | +14.3% |
| Q1 2020 | $6,140,000 | -19.1% | 344,000 | -2.1% | 0.01% | 0.0% |
| Q4 2019 | $7,585,000 | +48.0% | 351,400 | +24.9% | 0.01% | +40.0% |
| Q3 2019 | $5,126,000 | -34.6% | 281,400 | +27.7% | 0.01% | -44.4% |
| Q2 2019 | $7,842,000 | -34.4% | 220,400 | -38.1% | 0.01% | -40.0% |
| Q1 2019 | $11,961,000 | -11.5% | 355,992 | -13.4% | 0.02% | -21.1% |
| Q4 2018 | $13,508,000 | -37.8% | 410,958 | +15.4% | 0.02% | -32.1% |
| Q3 2018 | $21,701,000 | +66.8% | 355,988 | +33.6% | 0.03% | +55.6% |
| Q2 2018 | $13,007,000 | -57.8% | 266,378 | -8.2% | 0.02% | -59.1% |
| Q1 2018 | $30,841,000 | +121.3% | 290,242 | +24.4% | 0.04% | +131.6% |
| Q4 2017 | $13,937,000 | +197.5% | 233,379 | +19.6% | 0.02% | +171.4% |
| Q3 2017 | $4,685,000 | +25.5% | 195,200 | +2.3% | 0.01% | +16.7% |
| Q2 2017 | $3,732,000 | -14.9% | 190,900 | +2.2% | 0.01% | -14.3% |
| Q1 2017 | $4,384,000 | +83.4% | 186,800 | -4.2% | 0.01% | +75.0% |
| Q4 2016 | $2,391,000 | -28.6% | 194,900 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $3,348,000 | +13.0% | 194,900 | -6.4% | 0.01% | +20.0% |
| Q2 2016 | $2,964,000 | +0.3% | 208,300 | -3.0% | 0.01% | 0.0% |
| Q1 2016 | $2,954,000 | -23.0% | 214,800 | -5.7% | 0.01% | -16.7% |
| Q4 2015 | $3,838,000 | +53.7% | 227,800 | 0.0% | 0.01% | +50.0% |
| Q3 2015 | $2,497,000 | -15.2% | 227,800 | -3.3% | 0.00% | 0.0% |
| Q2 2015 | $2,946,000 | -20.4% | 235,500 | -4.8% | 0.00% | -20.0% |
| Q1 2015 | $3,702,000 | 0.0% | 247,316 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $3,702,000 | +30.3% | 247,316 | +5.0% | 0.01% | +25.0% |
| Q3 2014 | $2,842,000 | -19.4% | 235,500 | -14.4% | 0.00% | -20.0% |
| Q2 2014 | $3,526,000 | +11.8% | 275,058 | -4.7% | 0.01% | 0.0% |
| Q1 2014 | $3,153,000 | +25.8% | 288,521 | +35.1% | 0.01% | +25.0% |
| Q4 2013 | $2,507,000 | +44.8% | 213,521 | +28.9% | 0.00% | +33.3% |
| Q3 2013 | $1,731,000 | +22.6% | 165,674 | +35.5% | 0.00% | 0.0% |
| Q2 2013 | $1,412,000 | – | 122,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |